{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:27:22Z","timestamp":1786739242913,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To study the use of drugs in patients suffering from psoriasis and their effect on quality of life (QOL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a prospective, observational study carried out in newly diagnosed patient of psoriasis at Department of Pharmacology and Outpatient Department of Skin and Venereal diseases at tertiary care teaching hospital, and patients were divided into three groups: Group A: topical therapy alone, Group B: methotrexate with topical therapy, and Group C: cyclosporine with topical therapy. The efficacy of drug was measured using Psoriasis Area Severity Index (PASI). QOL was measured using Psoriasis Disability Index. Patients were followed up at 1 month and 6 months of treatment. Statistical analysis was done using analysis of variance (ANOVA) test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total 126 patients were enrolled, out of which 114 patients completed the study. PASI score was reduced significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) in each treatment group and QOL score was significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) decrease in Group B and C as compared to baseline at the end of 6 months. A significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) reduction in PASI score and QOL was observed in patients of Group B and C as compared to Group A. Correlation between efficacy and QOL was not significant in all three treatment groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Combination therapy (topical + systemic) is more efficacious and associated with significant improvement of QOL as compared to topical therapy alone. Methotrexate and cyclosporine are equally efficacious in treating and improving the QOL in patients suffering from psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_166_16","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T15:04:50Z","timestamp":1716476690000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life"],"prefix":"10.4103","volume":"49","author":[{"given":"V. V.","family":"Karamata","sequence":"first","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sutaria","sequence":"additional","affiliation":[{"name":"Department of Skin and Venereal Disease, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260528","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4103\/0378-6323.72443","article-title":"Psoriasis in India: Prevalence and pattern","volume":"76","author":"Dogra","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R5-20260528","first-page":"13","article-title":"Quality of life issues and measurement in patients with psoriasis","volume":"2","author":"Tan","year":"2012","journal-title":"Psoriasis Targets Ther"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4103\/2229-5178.193908","article-title":"General measures and quality of life issues in psoriasis","volume":"7","author":"Sarkar","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"R8-20260528","first-page":"238","article-title":"Severe psoriasis \u2013 oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2133.1990.tb04192.x","article-title":"Validation of sickness impact profile and Psoriasis Disability Index in psoriasis","volume":"123","author":"Finlay","year":"1990","journal-title":"Br J Dermatol"},{"key":"R11-20260528","first-page":"186","article-title":"Quality of life in patients with psoriasis in northern Taiwan","volume":"34","author":"Lin","year":"2011","journal-title":"Chang Gung Med J"},{"key":"R12-20260528","first-page":"87","article-title":"Clinical presentation of psoriasis in a tertiary care hospital of Khyber Pakhtunkhwa","volume":"20","author":"Rauf","year":"2012","journal-title":"J Med Sci"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0378-6323.45218","article-title":"Presentation of early onset psoriasis in comparison with late onset psoriasis: A clinical study from Pakistan","volume":"75","author":"Ejaz","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1468-3083.2001.00192.x","article-title":"The prevalence of psoriasis in the world","volume":"15","author":"Raychaudhuri","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7241\/ourd.20131.03","article-title":"Clinical evaluation of different therapeutic modalities in psoriasis by PASI score","volume":"4","author":"Puri","year":"2013","journal-title":"Our Dermatol Online"},{"key":"R16-20260528","first-page":"15","article-title":"Comparative study of methotrexate and cyclosporine in the treatment of psoriasis","volume":"9","author":"Karn","year":"2010","journal-title":"NJDVL"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ad.2013.02.018","article-title":"Impact of active and stable psoriasis on health-related quality of life: The PSO-LIFE study","volume":"104","author":"Daud\u00e9n","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-4632.2004.02237.x","article-title":"The Psoriasis Disability Index in Chinese patients: Contribution of clinical and psychological variables","volume":"44","author":"Yang","year":"2005","journal-title":"Int J Dermatol"},{"key":"R20-20260528","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5455\/msm.2014.26.168-171","article-title":"An epidemiological study on trigger factors and quality of life in psoriatic patients","volume":"26","author":"Xhaja","year":"2014","journal-title":"Mater Sociomed"},{"key":"R21-20260528","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/0019-5154.82482","article-title":"PASI and PQOL-12 score in psoriasis: Is there any correlation?","volume":"56","author":"Shankar","year":"2011","journal-title":"Indian J Dermatol"},{"key":"R22-20260528","first-page":"48","article-title":"Real-life effectiveness of topical Vitamin D and corticosteroid combination therapy in psoriasis: Moving beyond clinical trials","volume":"8","author":"Zeichner","year":"2015","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363791-201749010-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:27:09Z","timestamp":1786735629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_166_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_166_16","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"2016-03-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}